Skip to main content
. Author manuscript; available in PMC: 2012 Jul 15.
Published in final edited form as: J Immunol. 2011 Jun 15;187(2):1023–1030. doi: 10.4049/jimmunol.1004195

Figure 5. Higher prevalence of anti-CM antibodies than Donor Specific Antibodies (DSA) in patients with CAV.

Figure 5

Graphical depiction of the prevalence of donor-HLA reactive antibodies and anti-CM antibodies, with 95% confidence intervals (vertical lines), in the 20 CAV patients that screened positive for anti-HLA antibodies by screening tests. Because the confidence intervals do not overlap the differences are statistically significant.